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Three Dimensional Reconstructions of the Left Phrenic Nerve Anatomy in
Relation to the Coronary Venous System
Julianne Spencer1, Ryan P. Goff1, Paul A. Iaizzo1
1University of Minnesota, Minneapolis, MN
Background: Phrenic nerve stimulation (PNS) occurs during left-sided lead
implantations within the coronary venous system in over a third of patients. An
understanding of left phrenic nerve anatomy in relation to the coronary veins is
essential for reducing PNS.
Methods:Weobtained computed tomography (CT) scanswhile injecting contrast into the
coronary veins of 13 perfusion-ﬁxed human hearts with the pericardium and left phrenic
nerve intact. In order to visualize the location of the phrenic nerve under CT, we glued
a radiopaque wire to the nerve. We then created 3D models of the anatomy, displayed in
Figure 1, and measured relevant anatomical parameters (Materialise, Leuven, Belgium).Results: Table 1 presents the mean and standard deviations of various parameters
relating to areas where the phrenic nerve centerline intersects with the underlying
venous centerlines. The nerve intersected the closest to the left marginal veins,
which are typically targeted for left-sided lead implantations.Table 1. Mean and standard deviation values for various anatomical parame-
ters that characterize the locations where the phrenic nerve overlays the
coronary veins.
Vein
Prevalence of
phrenic nerve
overlapping
Shortest
distance to
the phrenic
nerve (mm)
Distance to
the coronary
sinus (mm)
Distance to
the coronary
sinus ostium
(mm)
Angle with
the phrenic
nerve ()
Coronary Sinus 23.1% 10.24.7 NA 90.812.6 120.753.2
Middle Cardiac Vein 30.8% 4.94.1 97.42.8 111.77.3 102.863.3
Inferior Vein 53.8% 5.02.4 102.914.4 127.427.8 94.939.7
Left Marginal Vein 53.8% 4.52.6 42.126.1 120.927.0 112.637.3
Anterior
Interventricular Vein
84.6% 7.24.1 27.516.8 98.155.0 104.755.0
Table 1. Data displayed in MeanSEM unless otherwise stated
ICE TEE
Female / Male 30/33 23/23
Device size (mm) 250.26 250.33
Fluoroscopy time (min) 9.11.4 91.6
Total procedure time (min) 752.5 803.8
Contrast (ml) 362.2 484.2*
Radiation dose (cGycm2) 1431186 1770339
Same day discharge (n/%) 50 / 79% 19 / 43%*
*p<0.05
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SConclusions: We found that the phrenic nerve overlaps a left marginal vein in over
half of the specimens in this sample. We will continue to expand this novel anatomical
database to provide further insights for PNS reduction during left-sided pacing.
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Background: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is known
as a serious disease with poor prognosis. Pulmonary endarterectomy (PEA) isJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstra treatment option, however, suitable indication is restricted within the proximal
lesions and few hospitals routinely perform PEA. In the present situation, we have
performed balloon pulmonary angioplasty (BPA) for the inoperable patients with
CTEPH in the distal pulmonary arteries since 2004, and introduced the reﬁned BPA
using intravascular ultrasound system since 2006. The purpose of the study was to
investigate the efﬁcacy and safety of BPA for inoperable patients with CTEPH who
hospitalized in Okayama Medical Center, Kagoshima Medical Center and Japanese
Red Cross Kyoto Daiichi Hospital.
Methods: The eligible population consisted of the consecutive 141 patients with
inoperative CTEPH who underwent reﬁned BPAs (626 sessions) in the three
collaborating hospitals. For the efﬁcacy, we investigated WHO functional class, 6
minutes walk distance, cardiac parameters using catheterization and BNP level. For
the safety, we evaluated major adverse event (emergent surgery, PCPS, mechanical
ventilator, NPPV for more than two days) and minor event (reperfusion pulmonary
injury without corresponding events mentioned above).
Results: The patients consisted of 30 males, 62.7 years at BPA, and the mean
morbidity period from the onset to 1st BPA was 2.8 years. Before the 1st BPA, WHO-
FC was 3.1, mean PAP: 44.9, Cardiac index: 2.4, PV resistance: 955.2, BNP: 268.3, 6
MWD: 266.3m, respectively. After BPA (average session number 3.0), WHO-FC was
1.9, mean PAP: 23.8, CI: 3.1, PVR: 321.7, BNP: 36.2, 6MWD: 357.1m, respectively.
Mean PAP at follow up was 21.9. Major adverse events were 7 PCPS and 13
mechanical ventilator. As minor adverse events, the number of pulmonary edema was
148 (chest X-ray) and 308 (CT scan), and 116 showed bloody phlegm. In-hospital
death was 5 (mortality 3.5%).
Conclusions: Although further improvement for equipment and technique should be
required, reﬁned BPA, which can safely improve the pulmonary circulation, is
considered to be an effective treatment option for inoperable patients with CTEPH.
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Comparison of Outcomes in Percutaneous Device Closure of Patent Foramen
Ovale Using Transesophageal And Intracardiac Echocardiography
Hani Abdel-Hadi1, Heiko Schneider2, Bernard Clarke1, Vaikom S. Mahadevan1
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Background: Percutaneous closure of the patent foramen ovale (PFO) is a common
procedure in structural cardiology and is mostly performed with transesophageal
echocardiography (TEE) guidance under general anaesthetic (GA). The use of intra-
cardiac echocardiography (ICE) has gained increased popularity as it avoids the need
for general anaesthesia, thereby reducing procedural time, risk and length of hospital
stay. This study compares clinical outcomes of PFO closure using ICE with TEE
Methods: We performed a retrospective analysis of 109 consecutive patients
(meanSEM 451.3 years, 56 male) undergoing elective PFO closure at a single
centre between 2005 and 2012 (46 TEE, 63 ICE). The indications for closure include
thromboembolic (n¼91), Migraine (7), Decompression sickness (4) and other (7).
Procedure data including duration, ﬂuoroscopy time, radiation dose, contrast load and
major complications were obtained. Follow up data at 3-6 months post procedure
collected include symptom recurrence, atrial ﬁbrillation and evidence of shunting on
echocardiography.
Results: There were no major adverse procedural events in either group. Hospital stay
and contrast usage were signiﬁcantly lower in the ICE group. There was a non-
signiﬁcant trend towards lower radiation doses and shorter procedure duration in the
ICE group. Follow up data was available in 104 patients (95%). There was no
evidence of any signiﬁcant shunting across the intra-atrial septum in any of the
patients. 1 patient had bubble contrast detected late in the cardiac cycle which was felt
to be not via the defect. 1 patient in the TEE group developed atrial ﬁbrillation which
was successfully cardioverted with no evidence of recurrence on further follow up.Conclusions: Using ICE in PFO closure is associated with signiﬁcantly shorter
hospital stay, lower contrast usage and avoidance of GA. Procedural outcomes are
comparable with both techniques.acts/POSTER/Non-valvular Structural Heart Disease B207
